Publikasi

Backed by $165M, Bionyra Pharma Launches to Advance Inf...

The company, which emerged from stealth this week, is using the funds to develop...

Pharma Friday – June 26, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...

Teeth Spacing: Causes, Concerns, and Treatment Options

10 things you didn't know about your teeth: A tooth can come in with a cavity an...

Intravesical CAR T-Cell Therapy Reduces Bladder Cancer ...

Researchers identified the protein MUC16 as a clinically relevant target for bla...

Genome Editing at the Turning Point—Bringing CRISPR to ...

This GEN Live show will bring together a panel of leading experts to break down ...

Underbite: Causes, Symptoms, and Treatment Options

10 things you didn't know about your teeth: A tooth can come in with a cavity an...

Circio’s circVec and Tcelltech’s nanoSMAR Technologies ...

Circio and Tcelltech will combine Circio's circVec circular RNA expression techn...

Nipah and Hendra Viruses: Antibody Cocktail Provides Co...

Researchers developed the first human antibody cocktail to completely protect ag...

Does dentistry have a problem with perfectionism?

Robbie Stewart explains how perfectionism is holding back talented clinicians an...

How a mirror defined the visual identity of Vogue Dental

Unforgettable design has become as important as clinical excellence in private d...

Heat waves mess with your brain. Scientists are trying ...

It’s been hot in London this week. Really hot. A dangerous heat wave has hit Wes...

Immunai and Boehringer partner to identify T-cell targets

The initial phase of the partnership, valued at up to $15m and running until 202...

Ionis grants Recordati rights to zilganersen for Alexan...

Ionis will retain the responsibility for commercialising the RNA-targeted medici...

Zydus Lifesciences, Sunshine Healthcare sign JV to set ...

The facility, to be located at the Board of Investment zone in Horana, will be ...

Centre notifies Drugs (Seventh Amendment) Rules, 2026

Expands Schedule H2 to include vaccines, antimicrobials and anticancer drugs Th...

Alembic gets USFDA nod for Oseltamivir Phosphate for Or...

Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated f...